Ondansetron HCl Orally Disintegrating Tablets Under Non-Fasting Conditions
Clinical trial NCT00934921 · COMPLETED
Trial details
- NCT number
- NCT00934921
- Sponsor
- Teva Pharmaceuticals USA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-01
- Primary completion
- 2003-02-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.